Summary
The aim of this study was to investigate whether determination of the initial cerebrospinal fluid (CSF) protein concentration and leukocyte count in children with acute lymphoblastic leukemia (ALL) could yield useful information about the patient's central nervous system status and prognosis. The population-based unselected series comprised 160 children. The mean follow-up time was 72 months (range 25–143 months). Both the CSF protein concentration and the leukocyte count, if elevated, were significantly, although not independently, associated with diminished probability of event-free survival. The patients were divided into three groups for the final analyses: those without any abnormalities in the CSF (n=133), those with elevated protein concentration and/or elevated leukocyte count, but with no malignant lymphoblasts in the CSF (n=21)), and those with malignant lymphoblasts in the CSF (n=6). The probabilities of 5-year event-free survival for the first and second group were 65% and 15%; the probability of 2-year event-free survival for the third group was 17%. These differences were statistically significant (p<0.001). In multivariate analysis the relative risks of death or relapse for these groups were 1, 2.8 (95% confidence limits 1.5–4.9), and 7.6 (2.4–24.3), respectively (p<0.001). The inclusion of an elevated CSF protein concentration or leukocyte count in the risk group criteria of further trials should be considered.
Similar content being viewed by others
References
Asami T, Tanaka A, Gunji T, Sakai K, Asami K (1987) Elevation of cerebrospinal fluid sialic acid concentration in children with central nervous system leukemia. Acta Paediatr Scand 76: 260–265
Dixon WJ (ed) (1983) BMDP statistical software (1983 revised printing). University of California Press, Los Angeles
Gustafsson G, Kreuger A (1983) Sex and other prognostic factors in acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol 5: 243–250
Gustafsson G, Kreuger A (1986) Prognosis after relapse in acute lymphoblastic leukemia in childhood. Pediatr Hematol Oncol 3: 119–126
Gustafsson G, Garwicz S, Hertz H, Jonmundsson G, Johannesson G, Moe PJ, Salmi T, Seip M, Siimes MA, Yssing M, Åhlström L (1987) Childhood acute lymphoblastic leukemia in the Nordic countries. A survey of children diagnosed July 1981 to July 1985. Acta Paediatr Scand 76: 781–788
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Mandelli F, Amadori S, Ceci A, Guazzelli C, Madon E, Marchi A, Masera G, Paolucci G, Zanesco L (1981) Long-term survival in childhood acute lymphocytic leukemia in Italy. Cancer 48: 2364–2367
Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D'Angio G (1986) Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 14: 191–194
Miller DR, Leikin S, Albo V, Vitale L, Sather H, Coccia P, Nesbit M, Karon M, Hammond D (1980) Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group report. Cancer Treat Rep 64: 381–392
Miller DR, Leikin S, Albo V, Sather H, Karon M, Hammond D (1983) Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. Cancer 51: 1041–1049
Palmer MK, Hann IM, Jones PM, Evans DIK (1980) A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia. Br J Cancer 42: 841–849
Riehm HJ, Gadner H, Henze G, Langermann HJ, Odenwald E (1980) The Berlin childhood acute lymphoblastic leukemia therapy study, 1970–76. Am J Pediatr Hematol Oncol 2: 299–306
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rautonen, J. Elevated cerebrospinal fluid leukocyte count and protein concentration at diagnosis: independent risk factors in children with acute lymphoblastic leukemia. Blut 56, 265–268 (1988). https://doi.org/10.1007/BF00320287
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320287